Agrin as a potential therapy for cartilage regeneration and pain relief for osteoarthritis- BBC Radio 5 Live, daily newspaper and other media outlets
Prof Francesco Dell’Accio and co-inventor Dr Suzanne Eldridge worked with Queen Mary Innovation to file a patent on a novel therapy shown to regenerate defective cartilage and bone, and improve pain management. This was seen in osteoarthritis models for up to 6 months with a single low dose administration. The Dell’Accio group’s publication in Science Translational Medicine received high levels of media coverage. QMI is marketing this technology to support partnering with companies for further development.
For further information contact the QMI Biopharma team.